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Abstract
Aims To investigate whether the association of severe mental illness with Type 2 diabetes varies by ethnicity and age.
Methods We conducted a cross-sectional analysis of data from an ethnically diverse sample of 588 408 individuals
aged ≥18 years, registered to 98% of general practices (primary care) in London, UK. The outcome of interest was
prevalent Type 2 diabetes.
Results Relative to people without severe mental illness, the relative risk of Type 2 diabetes in people with severe
mental illness was greatest in the youngest age groups. In the white British group the relative risks were 9.99 (95% CI
5.34, 18.69) in those aged 18–34 years, 2.89 (95% CI 2.43, 3.45) in those aged 35–54 years and 1.16 (95% CI 1.04,
1.30) in those aged ≥55 years, with similar trends across all ethnic minority groups. Additional adjustment for anti-
psychotic prescriptions only marginally attenuated the associations. Assessment of estimated prevalence of Type 2
diabetes in severe mental illness by ethnicity (absolute measures of effect) indicated that the association between severe
mental illness and Type 2 diabetes was more marked in ethnic minorities than in the white British group with severe
mental illness, especially for Indian, Pakistani and Bangladeshi individuals with severe mental illness.
Conclusions The relative risk of Type 2 diabetes is elevated in younger populations. Most associations persisted despite
adjustment for anti-psychotic prescriptions. Ethnic minority groups had a higher prevalence of Type 2 diabetes in the
presence of severe mental illness. Future research and policy, particularly with respect to screening and clinical care for
Type 2 diabetes in populations with severe mental illness, should take these findings into account.
Diabet. Med. 00, 000–000 (2017)
Introduction
Life expectancy in people with severe mental illness, such as
schizophrenia, bipolar affective disorder and other non-
organic psychoses, is reduced by 15–20 years compared with
the general population [1]. A large proportion of these deaths
are accounted for by natural causes [2]. At least one third of
the reduction in life expectancy is attributable to cardiovas-
cular mortality [3]. Associated with this, the prevalence of
Type 2 diabetes mellitus is estimated to be two- to threefold
higher in people with severe mental illness compared with the
general population [4], with overall prevalence estimated to
be between 1.26 and 50% [5]. Proposed mechanisms include
impact of medications such as anti-psychotic drugs [5–7],
social deprivation and lifestyle [5,8], as well as the direct
effect of severe mental illness through chronic stress [8] or
mediated through changes in inflammatory markers and the
hypothalamic–pituitary–adrenal axis [4].
Some ethnic minority groups, such as black or Hispanic
people may be at a higher risk of Type 2 diabetes mellitus if
also diagnosed with severe mental illness [5,9]. Much of the
research in this area has been based on non-epidemiological
convenience samples from psychiatric clinics [9]. Irrespective
of the presence of severe mental illness, high prevalence of
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Type 2 diabetes mellitus have been reported in other ethnic
minority groups, including Bangladeshi, Pakistani, Indian,
black Caribbean and black African populations [10–12]. No
study has systematically assessed the prevalence of Type 2
diabetes mellitus in these groups when also diagnosed with
severe mental illness.
With this in mind, the aim of the present study was to
assess the association of severe mental illness with diabetes
mellitus, using a large cross-sectional dataset of patient
records from UK primary care. Practices were located in an
ethnically diverse urban location, where many ethnic minor-
ity people reside and where the incidence of severe mental
illness is elevated [13]. We hypothesized that the prevalence
of Type 2 diabetes mellitus in people with severe mental
illness would be more elevated in ethnic minority groups
already known to be at an increased risk of Type 2 diabetes
mellitus, specifically Indian, Pakistani, Bangladeshi, black
Caribbean and black African people, compared with white
British people [10], and that the added risk of living with
diabetes mellitus and severe mental illness for these groups
would be greater than for white British people with severe
mental illness and would persist after taking into account
anti-psychotic prescriptions, which are known to increase the
risk of Type 2 diabetes mellitus in populations with severe
mental illness. The present analysis is part of a larger study
designed to investigate cardiovascular health inequalities in
people with severe mental illness [13].
Methods
Design, setting and population
Data from individuals aged ≥18 years, registered to 189 of
the 192 general practices (98%) in the London boroughs of
Tower Hamlets, Newham, City of London, Hackney and
Lambeth were used for the analyses. Each of these boroughs
are resident to some of the largest ethnic minority
communities in the UK, including Bangladeshi, black
Caribbean and Black African communities; 51% of the
population in the study area self-identify as belonging to an
ethnic minority group [14]. All patient records for 1 year
before the date of extraction were included in the analyses.
This was 31 March 2013 for records from East London
(Tower Hamlets, Newham, City of London and Hackney)
and 31 October 2013 for records from Lambeth. Analyses
were cross-sectional; individuals were considered to have a
severe mental illness, Type 2 diabetes mellitus or to be on an
anti-psychotic prescription if there was a record of this at any
point in the observation period.
Measures
In the UK, 95% of the population is registered with general
practice. General practice is the first point of contact for the
National Health Service (NHS) and allows patient access to
family physicians, nurses or other community health staff
[15]. A pay-for-performance scheme, the Quality and Out-
comes Framework (QOF), was established as part of the GP
contract in 2004 [16] and covers the care of all individuals
registered to primary care in England [16]. The QOF
provides general practitioners (GPs) with a financial incen-
tive to keep an up-to-date register of people with a confirmed
diagnosis of schizophrenia, bipolar affective disorder and
non-organic psychosis [16] and means that people with these
disorders are recognized and recorded more frequently in UK
primary care [17]. At the time of this study, GPs were
incentivized to ensure that health checks in people with
severe mental illness, including the assessment of HbA1c and
glucose measurement, were undertaken annually [16]. Diag-
nostic Read codes [18] were used to derive main exposure
and outcome measures used in the analysis. Read codes are a
thesaurus of standardized clinical terms which provide the
means through which clinicians record patient health indi-
cators [18].
Exposure
Severe mental illness
Individuals with a diagnosis of schizophrenia, bipolar
affective disorder or non-organic psychosis were identified
using diagnostic codes and grouped together to form the
main exposure category of ‘severe mental illness’. The use
of computer-based electronic records to identify individuals
with severe mental illness in UK primary care has
previously been validated, with a sensitivity of 91% and
a positive predictive value of 91% for non-organic
psychosis assessed against a syndrome checklist derived
from the Present State Examination and International
Classification of Disease-9 (ICD-9) codes [19]. Recent
work has shown that in UK primary care, this diagnostic
grouping remains stable over time, and the incidence of
severe mental illness in primary care is broadly similar to
What’s new?
• There is limited evidence of the association of severe
mental illness with Type 2 diabetes mellitus in ethnic
minorities.
• Using data from >500 000 people, we established that:
(1) risk of Type 2 diabetes was increased up to 10-fold
in people with severe mental illness compared with
groups without severe mental illness, irrespective of
ethnicity, and was greatest in the youngest age groups;
(2) prevalence of Type 2 diabetes was highest in
Bangladeshi people with severe mental illness but was
also high in all other South Asian, black African and
black Caribbean groups; and (3) most associations
persisted despite adjustment for anti-psychotic prescrip-
tions.
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established epidemiological trends, with respect to gender,
age and socio-economic deprivation [17]. Up to one third
of people with severe mental illness may be registered with
a GP but not known to secondary care [20].
Outcome
Diagnoses of diabetes mellitus were ascertained by reviewing
diagnostic codes [18] entered by GPs as well as reviewing
entries on pharmacy records. A clinician (J.D.) manually
reviewed all diagnostic codes. Criteria for diagnosis of
diabetes mellitus were informed by approaches used in other
primary care database studies of diabetes mellitus, such as
the Health Improvement Network (THIN) [21] and the
Clinical Practice Research Datalink (CPRD) [22]. Figure 1
shows how Type 2 diabetes mellitus was determined.
Effect modifiers and confounders
Age at last birthday and gender were available for all
participants. Age was analysed as a continuous variable and
then categorized into three groups (18–34, 35–54 and
≥55 years). This afforded sufficient numbers within each
group to compare associations with Type 2 diabetes mellitus
by ethnicity. Measures for area-level deprivation were
derived by mapping postcodes of participants to Lower
Cases diabetes identified through 
diagnostic Read codes
Type 1 diabetes mellitus n=3308
Type 2 diabetes mellitus n=57915
no diabetes mellitus n=994991
Patients classified into type 1 or type 
2 diabetes
Type 1 diabetes mellitus n=3397
Type 2 diabetes mellitus n=58149
no diabetes mellitus n=994668
No Read code for diabetes but 
prescribed insulin
and:
≤34 years; Type 1 diabetes mellitus
n=89
≥35 years; Type 2 diabetes mellitus 
n=145
No Read code for diabetes but 
prescribed
sulfonylureas/ other hypoglycaemics
n=89*
Sample restricted to18+ years age
Type 1 diabetes mellitus n=3292
Type 2 diabetes mellitus n=58148
no diabetes mellitus n=931676
Sample restricted to18+ years age 
and main ethnic groups†
Type 1 diabetes mellitus n=2245
Type 2 diabetes mellitus n=44622
no diabetes mellitus n=541,541
total: n=588408
Excluded as not one of the main 
ethnic groups†
N=293171
Or missing data 
N=111537 
FIGURE 1 Flow chart of participants into study. *n = 764 people were prescribed Metformin only with no Read code for diabetes mellitus;
(Metformin is prescribed for other conditions) these patients were not included in the Type 2 diabetes mellitus group; †Main ethnic groups in the
study: white British, Irish, Indian, Pakistani, Bangladeshi, black Caribbean and black African. Excluded ethnic minority groups were mainly ‘other’
ethnic groups.
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Level Super Output Areas, which were then linked to the
Index of Multiple Deprivation (IMD 2010) [23]. Anti-
psychotic medications were assessed using data on prescrip-
tions, leading to a binary variable (prescribed anti-psychotics
or not prescribed anti-psychotics).
Ethnicity
Across the study sites, the recording of self-ascribed ethnicity
has been promoted through locally run incentive schemes,
with high levels of completeness on this variable. Self-
ascribed ethnicity mapped to the 2011 UK census categories
was used and categorized using approaches similar to
previous national surveys from England [10,11]. The resul-
tant ethnic groups were: white British; Irish; Indian; Pak-
istani; Bangladeshi; black Caribbean; and black African. The
Irish ethnicity group was retained as distinct to the white
British group, as previous research has indicated poorer
health outcomes in this group [24].
Statistical analysis
Generalized linear models with log link and Poisson distri-
bution [25] were used to derive relative risks [25]. Equal
follow-up times were attributed to individuals in these
models. Relative risks were chosen over odds ratios as the
outcome (Type 2 diabetes mellitus) was relatively prevalent
and, in these circumstances, odds ratios may overestimate the
prevalence ratio [26]. As the variation in binary data may be
overestimated using Poisson regression, a robust variance
estimator was initially used [25]. The 95% CIs derived using
this approach against approaches which used Poisson
regression with robust standard errors to account for
clustering by general practice were similar to three decimal
places. Models were stratified by age and ethnicity and
adjusted for (1) gender and area-level deprivation and (2)
gender, area-level deprivation and anti-psychotic prescrip-
tions, with clustering by general practice accounted for
through robust standard errors. This approach was used to
assess the crude and adjusted association of severe mental
illness with Type 2 diabetes mellitus, stratified by age and
ethnicity, leading to relative risks with 95% CIs.
In keeping with reporting guidelines, and in order to
provide a fuller assessment of potential inequalities, we also
opted to assess absolute measures of effect [27]. This
approach complemented the relative risk-based approach
and allowed us to clarify differences in baseline risk of Type 2
diabetes mellitus in ethnic groups and the effect of also being
diagnosed with severe mental illness (therefore leading to
estimates with more direct relevance to clinical practice).
Generalized linear models with a binomial distribution and an
identity link were used to derive adjusted risk differences for
Type 2 diabetes mellitus in people with severe mental illness
relative to those without severe mental illness [28], stratified
by ethnicity and age. The ‘margins’ command in STATA was
used to derive estimated prevalence from these models. Risk
difference models were implemented in STATA based on
Wacholder’s method [29]. All models adjusted for gender,
area-level deprivation and robust standard errors to account
for practice-level clustering. Analyses were complete case. All
statistical tests were two-tailed. Analyses were conducted in
STATA 13 [28].
Ethical approval
The study was approved by Kings College London Research
Ethics Committee. Locally, the South London Primary Care
Research Governance Team reviewed the process of anon-
ymized data analysis confirming that research governance
assurance was not required. As a secondary analysis of
anonymized data this study did not require national ethics
approval. The dataset was constructed by pooling primary
care data across boroughs; no data linkages were sought. The
pooled dataset has contributed to several observational
studies using anonymized data.
Results
Data for age, gender, practice location and anti-psychotic
prescriptions were complete. There were 33 656 (6%)
individuals without information on area-level deprivation
and 111 537 (11%) without information on ethnicity. After
restricting the analysis to participants who could be mapped
on to the main ethnic groups, data from 588 408 individuals,
aged ≥18 years and registered to 189 general practices, were
included in the analysis (Fig. 1). Table 1 shows the demo-
graphic features. Notably, slightly more people were pre-
scribed anti-psychotic medications than had a severe mental
illness diagnosis (Table 1).
Relative risk of Type 2 diabetes
Table 2 shows stratum-specific estimates for relative risk of
Type 2 diabetes in people with severe mental illness, relative
to those without severe mental illness, stratified by ethnicity
and age, and adjusted for gender and area-level deprivation
(model 1) and gender, area-level deprivation and anti-
psychotic prescriptions (model 2). Relative risk for the
association of severe mental illness with Type 2 diabetes
mellitus was strongest for individuals in the 18–34-year age
group, but reduced with increasing age. Adjustment for anti-
psychotic prescriptions only marginally attenuated associa-
tions. Trends were similar when age was broken down
further into 10-year bands (Table S1).
Prevalence of Type 2 diabetes mellitus in severe mental
illness
Overall, the estimated prevalence of Type 2 diabetes mellitus
was 16.0% (95% CI 15.1, 16.9) in people with severe mental
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illness [vs 7.6% (95% CI 7.3, 8.0) in people without severe
mental illness] after adjusting for gender and area-level
deprivation. Within each age band, the estimated prevalence
of Type 2 diabetes mellitus in people with severe mental
illness was 3.3% (95% CI 2.5, 4.0) at age 18–34 years,
14.3% (95% CI 13.0, 15.5) at age 35–54 years and 27.5%
(95% CI 25.6, 29.2) at age ≥55 years, after adjusting for
gender and area-level deprivation.
In stratified analyses the adjusted estimated prevalence of
Type 2 diabetes mellitus was increased in the presence of
severe mental illness, across all age and ethnic groups (Fig. 2).
Although there was a larger magnitude of risk of Type 2
diabetes mellitus (in relative terms) in the youngest age group
(Table 2), absolute estimates of prevalenceweremost elevated
for Bangladeshi people with severe mental illness, who had an
estimated prevalence of Type 2 diabetes mellitus of 7.6%
(95%CI 5.5–9.6) in the youngest age band (18–34 years); this
was 1.0% (95% CI 0.9–1.1) in the Bangladeshi population
without severe mental illness (Fig. 2). For the age group 35–
54 years, estimated prevalence of Type 2 diabetes mellitus
increased further across all ethnic groups living with severe
mental illness and was most notable for Indian, Pakistani,
Bangladeshi and black Caribbean people with severe mental
illness (Table S1 and Fig. 2). For the oldest age group (age
≥55 years) prevalence estimates for Type 2 diabetes mellitus
remained elevated in people with severe mental illness across
all ethnic groups, but was greatest for Bangladeshi people
living with severe mental illness, who had an estimated
prevalence of Type 2 diabetes mellitus of 63.8% (95% CI
58.2, 69.4; Table S1). Risk differences are shown in Table S1.
In models estimating absolute risk, within the three age bands,
there was strong evidence (P < 0.001) to indicate that the
association of severe mental illness with Type 2 diabetes
mellitus varied by ethnicity, with evidence of larger risk
differences for each of the ethnic minority groups compared
with the white British group (Table S1).
Discussion
The present study provides confirmatory evidence that the
prevalence of Type 2 diabetes mellitus is elevated in people
with severe mental illness. The findings also indicated that
this was more marked for the ethnic minorities surveyed in
this study. Relative to people not known to have severe
mental illness, the relative risk of Type 2 diabetes mellitus
was most elevated in young populations. In models esti-
mating absolute risk, estimated prevalence of Type 2
diabetes mellitus in people with severe mental illness was
elevated in most ethnic minority groups and especially
marked in Bangladeshi, Indian and Pakistani people.
Although adjustment for anti-psychotic prescriptions atten-
uated some of the association, on the whole, most of the
associations persisted.
The findings are in keeping with previous work which has
shown a strong association between severe mental illness and
Type 2 diabetes mellitus, not fully accounted for through
anti-psychotic prescribing [1,5,6]. Previous studies have
suggested the risk of Type 2 diabetes mellitus in people with
severe mental illness may be 2–4 times higher than in the
background population [30]. Although this magnitude of
association was confirmed in the present study for people
aged 35–54 years, in the youngest age group of 18–34 years,
the relative risk of Type 2 diabetes mellitus ranged between
3- and 10-fold, by age 55 years the relative risk for
association of severe mental illness with Type 2 diabetes
mellitus was diminished across all ethnic groups. Life
expectancy of people with severe mental illness is much
reduced [1], therefore, the findings may indicate a healthy
survivor effect among those with severe mental illness. A
similar trend has been demonstrated previously for cardio-
vascular and stroke mortality in people with severe mental
illness [30]. Findings may also reflect competing risks [31], in
other words, the increased risk of premature death from
related causes removes people from the ‘at-risk’ (severe
mental illness) population, leading to a reduced relative risk
of Type 2 diabetes in people with severe mental illness in the
oldest age groups. Future work using longitudinal data
linked to mortality records could be used to understand this
further. Another factor that may have accounted for these
findings is the fact that Type 2 diabetes mellitus is relatively
Table 1 Demographic features of the sample
Total sample, N (%) 588 408 (100)
Age group, n (%)
18–34 years 250 883 (43)
35–54 years 213 428 (36)
≥55 years 124 097 (21)
Gender, n (%)
Male 299 796 (51)
Female 288 612 (49)
Ethnicity, n (%)
White British 242 614 (41)
Irish 13 745 (2)
Indian 63 999 (11)
Pakistani 35 596 (6)
Bangladeshi 94 643 (16)
Black Caribbean 54 939 (9)
Black African 82 872 (14)
Area-level deprivation*, n (%)
Quintile 5 (most deprived) 370 313 (67)
Quintile 4 147 890 (27)
Quintile 3 28 657 (5)
Quintile 2 5532 (1)
Quintile 1 (least deprived) 2360 (<0.1)
Anti-psychotic prescriptions, n (%)
Not prescribed anti-psychotic
medication
577167 (98)
Prescribed anti-psychotic medication 11241 (2)
Severe mental illness, n (%)
No severe mental illness 577638 (98)
Severe mental illness 10770 (2)
Type 2 diabetes mellitus, n (%)
No diabetes mellitus 541541 (92)
Type 2 diabetes mellitus 44622 (8)
*Index of Multiple Deprivation at Lower-Level Super Output
Area.
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rare in young healthy populations (hence we observed higher
relative risks in the population with severe mental illness
relative to the populations without severe mental illness in
the younger age group)[4]; the steep rise in Type 2 diabetes
mellitus prevalence at older ages among those without severe
mental illnesses may have made larger relative risks in the
severe mental illness population less likely.
Findings from the additive models of risk, illustrating
differences in the prevalence of Type 2 diabetes mellitus,
indicated that ethnic minority groups are more likely to have
Type 2 diabetesmellitus in the presence of severemental illness
compared with white British people with severe mental
illnesses. These differences were marked; for example, by age
≥55 years, whereas white British individuals with severe
mental illness had a prevalence of Type 2 diabetes mellitus of
16.8% [95% CI 14.9, 18.6 (compared with white British
people without severe mental illnesses among whom the
prevalence was 13.8% (95%CI 13.2, 14.4)], in the Banglade-
shi group with severe mental illness this was 63.8% [95% CI
58.2, 69.4 (compared with 51.7% (95% CI 50.3, 53.1) in the
Bangladeshi group without severe mental illness (Fig. 2)].
Assessment of effect modification on an additive scale
suggested that the combined effect of ethnicity and severe
mental illness on Type 2 diabetes mellitus risk within age
bands was greater than the sum of the individual effects
(Table S2).
The relative risk for the association of severe mental illness
with Type 2 diabetes mellitus was elevated and persisted
across all ethnic groups, despite adjustment for anti-
psychotic medications. The finding of an increased risk of
Type 2 diabetes mellitus in severe mental illness, which
persisted despite adjustment for anti-psychotic prescriptions,
suggests other factors may operate which increase the risk of
diabetes in severe mental illnesses. This may include the
impact of severe mental illnesses on physical health and
ability to access preventative healthcare, relevant to all
people with severe mental illnesses, irrespective of ethnicity.
The present analyses are based on a large primary care
database, covering 98% of practices in a well-defined
ethnically diverse location in the UK. This population is
likely to be representative of other ethnically diverse regions
in inner cities and could be generalized to other similar
contexts. Local initiatives to improve the recording of self-
ascribed ethnicity meant that this variable was relatively
complete. The large sample size with relatively complete
encoding for self-ascribed ethnicity meant that it was
possible to assess differences in prevalence estimates of Type
2 diabetes mellitus without recourse to grouped categories
(e.g. ‘South Asian’ or ‘Black’). Using such an approach
highlighted intra-ethnic differences in the prevalence of Type
2 diabetes mellitus with the comorbidity of severe mental
illness. A limitation is that we did not have information
relating to country of birth and family origins, which may
have permitted a more nuanced assessment of ethnicity [32].
Previous studies have highlighted the fact that a high
proportion of people with severe mental illness may have
undetected diabetes mellitus [4]. At the time of this study,
screening for Type 2 diabetes mellitus in people aged
Table 2 Relative risk (95% CI) of Type 2 diabetes mellitus in people with severe mental illness vs no severe mental illness
No severe
mental illness
Severe mental
illness
Age group
18–34 years 35–54 years ≥55 years
With/without
Type 2 diabetes,
n/n
With/without
Type 2 diabetes,
n/n Relative risk (95% CI) Relative risk (95% CI) Relative risk (95% CI)
Ethnicity
White British 10 775/22 6175 433/3951 9.81 (5.25, 18.36)
8.77 (4.69, 16.40)
2.88 (2.42, 3.44)
2.54 (2.13, 3.02)
1.17 (1.04, 1.31)
1.08 (0.96, 1.21)
Irish 562/12845 34/249 –
–
2.84 (1.04, 7.79)
2.50 (0.92, 6.81)
1.60 (1.16, 2.20)
1.47 (1.07, 2.03)
Indian 5433/57824 134/482 6.01 (2.32, 15.59)
5.20 (2.01, 13.41)
2.08 (1.59, 2.72)
1.78 (1.36, 2.34)
1.13 (0.96, 1.32)
1.02 (0.87, 1.21)
Pakistani 3071/32073 79/300 5.26 (1.70, 16.26)
4.54 (1.48, 13.99)
2.14 (1.59, 2.89)
1.81 (1.33, 2.47)
1.23 (0.99, 1.53)
1.11 (0.88, 1.39)
Bangladeshi 10 965/82 056 419/1076 7.28 (5.51, 9.63)
6.18 (4.62, 8.28)
2.02 (1.77, 2.31)
1.71 (1.48, 1.98)
1.25 (1.14, 1.37)
1.12 (1.03, 1.23)
Black Caribbean 6427/46 204 406/1596 8.31 (4.16, 16.60)
7.32 (3.66, 14.63)
2.36(2.01 2.77)
2.06 (1.74, 2.44)
1.13 (1.02, 1.26)
1.04 (0.94,1.15)
Black African 5688/75 350 196/1360 3.45 (1.54, 7.76)
3.00 (1.34, 6.73)
2.13 (1.73, 2.62)
1.85 (1.48, 2.31)
1.11 (0.90, 1.35)
0.99 (0.81, 1.22)
Wald test for interaction
of ethnicity and severe
mental illness,
within age group
<0.001 0.02 0.38
–, too few observations to derive estimates.
Model 1: (set in roman) adjusted for gender and area-level deprivation; Model 2: (set in italic) adjusted for gender, area-deprivation level,
anti-psychotic prescriptions.
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FIGURE 2 Estimated prevalence of Type 2 diabetes mellitus by severe mental illness, ethnicity and age, adjusted for gender, areal-deprivation and
clustering by practice (Table S3).
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> 40 years with severe mental illness was still financially
incentivised nationally, with high rates of completion (e.g.
82.8% completion in the London area; https://www.
gpcontract.co.uk/browse/08K/Mental%20Health/13). Given
this high response rate, a relative strength of the present
study is that the prevalence estimates of Type 2 diabetes
mellitus in the population with severe mental illness are likely
to have been relatively accurate in those aged >40 years;
however, it is possible that rates of diagnosis may have been
lower in individuals with severe mental illnesses aged
<40 years, because this was not incentivised. Despite this,
the detected prevalence of Type 2 diabetes mellitus remained
appreciably higher in the youngest age group, which is a
concern as this may have been an underestimate. Although a
healthy survivor effect could account for the findings in the
oldest age group, the cross-sectional nature of this dataset
means that it is not possible to be certain about this, nor the
temporal association of severe mental illness and diabetes.
The differential association of severe mental illness with
Type 2 diabetes mellitus by age could have been accentuated
by ascertainment biases, as incident Type 2 diabetes mellitus
may have been less likely to have been ascertained in older
people with severe mental illness as there may be less
attention to medication side effects in this age group,
especially if people had been on a stable regime for long
periods of time. It is also possible that older people with
chronic mental disorders are less likely to visit GPs, complain
of relevant symptoms, or have family members who can
assist and advocate for them, which could have also led to a
lower reported prevalence of Type 2 diabetes mellitus in this
group. The prevalence estimates may have been residually
confounded by social deprivation over and above the area-
level deprivation measures.
Although we adjusted for anti-psychotic medication pre-
scriptions, most associations persisted. We could not adjust
for BMI because of high levels of missing data for this
variable. Future research should consider this and other
mediators, potentially on the causal pathway, preferably
using longitudinal data.
Efforts to concentrate case-finding and management
should include Type 2 diabetes mellitus screening in younger
populations with severe mental illness. A previous systematic
review indicated that the prevalence of Type 2 diabetes
mellitus is elevated in ethnic minority groups across Euro-
pean settings (especially in South Asian, Middle Eastern and
North African, Sub-Saharan African and South/Central
American populations [12]). The findings of the present
study support a similar trend, but importantly, indicate that
some ethnic minority groups may be even more likely to have
Type 2 diabetes mellitus with the additional presence of
severe mental illness.
In conclusion, these findings potentially inform current
discussions on screening for diabetes mellitus in severe
mental illness, particularly in younger populations and in
areas which are ethnically diverse. Screening should not just
be restricted to people prescribed anti-psychotic medications.
Current debates around screening for Type 2 diabetes
mellitus in severe mental illness will also need to be informed
by evidence of benefit from screening. The findings also have
implications for the clinical care of all individuals living with
severe mental illnesses as, irrespective of ethnicity, Type 2
diabetes mellitus is more prevalent.
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